XDR-TB: A Special News Recap Discussion
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
In this segment, Dr. Pavia examines the case of patient Andrew Speaker, who is publicly struggling with Extensively Drug-Resistant (XDR) Tuberculosis, and the state of American Public Health Care Systems responding to the threat of transmission with this dangerous infectious disease. The interview clarifies distinctions between XDR-Tuberculosis and the more classical Multi-Drug-Resistant Tuberculosis, and follows with a discussion on some of the challenges faced by those organizations working to prevent and control spread of major infectious diseases.
Overview
In this segment, Dr. Pavia examines the case of patient Andrew Speaker, who is publicly struggling with Extensively Drug-Resistant (XDR) Tuberculosis, and the state of American Public Health Care Systems responding to the threat of transmission with this dangerous infectious disease. The interview clarifies distinctions between XDR-Tuberculosis and the more classical Multi-Drug-Resistant Tuberculosis, and follows with a discussion on some of the challenges faced by those organizations working to prevent and control spread of major infectious diseases.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Personalizing Care Within the RCC Treatment Paradigm
Navigating Myasthenia Gravis in Adolescents and Young Adults
AI and Hair Loss: Measuring Progress with Data-Driven Insights
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?